FARALLON CAPITAL MANAGEMENT LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,237,000
-97.2%
31,900
-95.8%
0.01%
-97.3%
Q4 2021$44,317,000
-67.7%
757,425
-67.2%
0.22%
-65.4%
Q3 2021$136,997,000
-17.1%
2,311,398
+21.3%
0.64%
-5.3%
Q2 2021$165,335,000
+5.5%
1,905,000
+0.3%
0.68%
-13.2%
Q1 2021$156,655,000
-42.6%
1,900,000
-36.7%
0.78%
-52.6%
Q4 2020$272,790,000
+118.4%
3,000,000
-4.0%
1.64%
+89.9%
Q3 2020$124,906,000
+4.0%
3,125,000
-10.7%
0.86%
-10.1%
Q2 2020$120,085,000
+80.2%
3,500,000
+16.7%
0.96%
+68.0%
Q1 2020$66,630,000
+51.3%
3,000,000
+33.3%
0.57%
+92.6%
Q4 2019$44,033,000
+26.0%
2,250,0000.0%0.30%
+12.5%
Q3 2019$34,943,000
-31.1%
2,250,000
-10.0%
0.26%
-20.0%
Q2 2019$50,750,000
+15.5%
2,500,0000.0%0.33%0.0%
Q1 2019$43,925,000
+55.6%
2,500,000
+13.6%
0.33%
+59.4%
Q4 2018$28,226,000
+226.9%
2,200,000
+315.1%
0.21%
+305.9%
Q3 2018$8,634,000
+881.1%
530,000
+209.6%
0.05%
+264.3%
Q3 2014$880,000
-43.8%
171,196
-31.0%
0.01%
-39.1%
Q2 2014$1,566,000
-41.5%
248,102
-9.8%
0.02%
-56.6%
Q1 2014$2,679,000
-21.6%
275,000
-49.5%
0.05%
-25.4%
Q4 2013$3,418,000544,2430.07%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders